Sfoglia per SSD
Lipid transfer protein in diagnosis of birch-apple syndrome in children
2008 B. Cudowska, M. Kaczmarski, P. Restani
Lipids in functional foods, nutraceuticals and supplements
2012 C. Ballabio, P. Restani
Lipophilicity-antifungal activity relationships for some isoflavonoid phytoalexins
1990 A. Arnoldi, L. Merlini
Liquid chromatographic determination of imazosulfuron in drinking water and in soil using ultraviolet detection
1999 M. Ventriglia, P. Restani, P. Morrica, P. David, L. De Angelis, C.L. Galli
Low molecular weight colored compounds formed in xylose-lysine model systems
1993 J.M. Ames, A. Apriyantono, A. Arnoldi
Lupin LILPKHSDAD (P5) peptide is a novel bi-functional inhibitor of PCSK9, a new target for the hypercholesterolemia treatment
2018 C. Lammi, G. Grazioso, C. Bollati, G. Aiello, G. Vistoli, A. Arnoldi
Lupin Peptide T9 (GQEQSHQDEGVIVR) Modulates the Mutant PCSK9D374Y Pathway : in vitro Characterization of its Dual Hypocholesterolemic Behavior
2019 C. Lammi, C. Bollati, D. Lecca, M.P. Abbracchio, A. Arnoldi
Lupin peptides induce hypocholesterolemic effects through the regulation of the post-translation HMGCoAR activity on HepG2 cells
2015 C. Zanoni, C. Lammi, A. Arnoldi
Lupin peptides induce the LDL receptor / SREBP2 pathway at HEPG2 cell line
2014 C. Lammi, C. Zanoni, G.M. Scigliuolo, A. D’Amato, A. Arnoldi
Lupin peptides lower LDL cholesterol through an up-regulation of LDL receptor / SREBP2 pathway at HepG2 cell line
2014 C. Lammi, C. Zanoni, G. Scigliuolo, A. D’Amato, A. Arnoldi
Lupin Peptides Lower Low-Density Lipoprotein (LDL) Cholesterol through an Up-regulation of the LDL Receptor/Sterol Regulatory Element Binding Protein 2 (SREBP2) Pathway at HepG2 Cell Line
2014 C. Lammi, C. Zanoni, G.M. Scigliuolo, A. D'Amato, A. Arnoldi
Lupin peptides modulate the protein-protein interaction of PCSK9 with the low density lipoprotein receptor in HepG2 cells
2016 C. Lammi, C. Zanoni, G. Aiello, A. Arnoldi, G. Grazioso
Lupin peptides: novel bi-functional inhibitors of PCSK9, a new target for the cardiovascular disease risk reduction
2017 C. Lammi, C. Zanoni, G. Aiello, A. Arnoldi
Lupin protein (Lupinus albus) intake decrease blood pressure and other cardiovascular risk factors in smokers. A pilot study
2007 M. Naruszewicz, G. Nowicka, L. Kosiewicz Latoszek, A. Arnoldi, C. Sirtori
Lupin protein exerts cholesterol-lowering effects targeting PCSK9: from clinical evidences to elucidation of the in vitro molecular mechanism using HepG2 cells
2016 C. Lammi, C. Zanoni, L. Calabresi, A. Arnoldi
Lupin protein isolates with valuable technological properties and minimum thermal damage
2007 D. Resta, G. Boschin, A. D’Agostina, J. Bez, M. Schott, U. Knauf, A. Arnoldi
LUPIN PROTEINS AS FOOD INGREDIENTS: DEVELOPMENT AND OPTIMIZATION OF LABEL-FREE METHODS FOR THE QUANTITATIVE ANALYSIS IN MASS SPECTROMETRY
2010 D. Resta
Lupin proteins in the treatment of hypercholesterolemia
2006 G. Nowicka, L. KLOSIEWICZ LATOSZEK, C.R. Sirtori, A. Arnoldi, M. Naruszewicz
Lupin-Derived Bioactive Peptides: Intestinal Transport, Bioavailability and Health Benefits
2021 I. Okagu, J. Ndefo, E. Aham, J. Obeme-Nmom, P. Agboinghale, R. Aguchem, R. Nechi, C. Lammi
Lupin-derived compounds having hypotensive activity and process for their production
2013 A. Arnoldi, G. Boschin, D. Resta, G. Scigliuolo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile